Weekly Lonapegsomatropin in Treatment-Na ïve Children with Growth Hormone Deficiency: The Phase 3 heiGHt Trial

CONCLUSIONS: The trial met its primary objective of non-inferiority in AHV and further showed superiority of lonapegsomatropin compared to daily somatropin, with similar safety, in treatment-naïve children with GHD.PMID:34272849 | DOI:10.1210/clinem/dgab529

Source: The Journal of Clinical Endocrinology and Metabolism - July 17, 2021 Category: Endocrinology Authors: Paul S Thornton Aristides K Maniatis Elena Aghajanova Elena Chertok Elpis Vlachopapadopoulou Zhengning Lin Wenjie Song Eva Dam Christoffersen Vibeke Miller Breinholt Tatiana Kovalenko Elene Giorgadze Maria Korpal-Szczyrska Paul L Hofman David B Karpf Aime Source Type: research